Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sullivan

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Heart, Lung & Circulation|September 3, 2020
Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National RegistryJing Pang, David R Sullivan, David L Hare, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Ebiomedicine|October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinaseHui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Atherosclerosis. Supplements|September 16, 2011
Familial hypercholesterolaemia: a model of care for AustralasiaGerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Heart, Lung & Circulation|September 3, 2020
Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National RegistryJing Pang, David R Sullivan, David L Hare, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Ebiomedicine|October 17, 2021
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinaseHui-Ming Lin, Blossom Mak, Nicole Yeung, et al.
Atherosclerosis. Supplements|September 16, 2011
Familial hypercholesterolaemia: a model of care for AustralasiaGerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Pageof 11